Push-Pull OPEs in Blue-Light Anticancer Photodynamic Therapy
Molecules · 2025
DOI: 10.3390/molecules30112310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ana Lameiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, 28049 Madrid, Spain. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Light, Antineoplastic Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Photodynamic therapy (PDT) is a minimally invasive technique—used for the local eradication of neoplastic cells—that exploits the interaction of light, oxygen, and a photo-responsive drug called photosensitizer (PS) for the local generation of lethal ROS. Push-pull chromophores, that bear electron donor (D) and acceptor (A) groups linked through a π-electron bridge, are characterized by a non-homogeneous charge distribution in their excited state, with charge transfer from one extremity of the chain to the other one (Internal Charge Transfer—ICT). This phenomenon has a direct impact on the photophysical features of the push-pull compounds, as the bathochromic shift of the emission maxima and intersystem crossing (ISC) of the excited state are directly connected with the production of reactive oxygen species (ROS). In continuing our research regarding the synthesis and use of oligophenylene ethynylenes (OPEs) in PDT, two new push-pull glycosyl OPE-NOF and OPE-ONF—featuring electron-donor N,N-dimethylamino (N) and dimetoxyaryl (O) and acceptor tetrafluoroaryl (F) moieties on the OPE chain—have been efficiently prepared. The interchanged position of the D groups onto the conjugated skeleton was aimed to tune and optimize the push-pull effect, while the introduction of glucoside terminations was directed to give biocompatibility and bioaffinity to the chromophores. OPE-NOF, OPE-ONF, and the synthetic intermediates were fully characterized, and their photophysical properties were investigated by using UV-Vis absorption and emission spectroscopy. OPE-NOF showed a strong charge-transfer character and high PDT effect on HeLa cancer cells when irradiated with non-harmful blue light, causing massive cancer cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali (ChiBioFarAm), Università degli Studi di Messina, 98166 Messina, Italy.
ORCID-Profile: Ana Lameiro, Chiara M A Gangemi, Paola Maria Bonaccorsi, Maria Letizia Di Pietro, Silvia Gómez-Pastor, Fausto Puntoriero, Francisco Sanz-Rodríguez, Anna Barattucci
Zitieren
APA
Lameiro, A., Gangemi, C. M. A., Mancuso, A., Bonaccorsi, P. M., Di Pietro, M. L., Gómez-Pastor, S., Puntoriero, F., Sanz-Rodríguez, F., & Barattucci, A. (2025). Push-Pull OPEs in Blue-Light Anticancer Photodynamic Therapy. Molecules. https://doi.org/10.3390/molecules30112310
Vancouver
Lameiro A, Gangemi CMA, Mancuso A, Bonaccorsi PM, Di Pietro ML, Gómez-Pastor S, et al. Push-Pull OPEs in Blue-Light Anticancer Photodynamic Therapy. Molecules. 2025. doi:10.3390/molecules30112310
BibTeX
@article{Lameiro2025,
author = {Lameiro, Ana and Gangemi, Chiara M A and Mancuso, Aurora and Bonaccorsi, Paola Maria and Di Pietro, Maria Letizia and Gómez-Pastor, Silvia and Puntoriero, Fausto and Sanz-Rodríguez, Francisco and Barattucci, Anna},
title = {Push-Pull OPEs in Blue-Light Anticancer Photodynamic Therapy},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30112310}
}
EUVIMED